Details for Patent: 10,940,146

Which drugs does patent 10,940,146 protect, and when does it expire?

Patent 10,940,146 protects XPHOZAH and is included in one NDA.

This patent has fifty patent family members in twenty-seven countries.

Drugs Protected by US Patent 10,940,146

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ardelyx Inc	XPHOZAH	tenapanor hydrochloride	TABLET;ORAL	213931-001	Oct 17, 2023		DISCN	Yes	No	10,940,146					TREATMENT OF HYPERPHOSPHATEMIA
Ardelyx Inc	XPHOZAH	tenapanor hydrochloride	TABLET;ORAL	213931-001	Oct 17, 2023		DISCN	Yes	No	10,940,146					REDUCTION OF SERUM PHOSPHORUS IN ADULTS
Ardelyx Inc	XPHOZAH	tenapanor hydrochloride	TABLET;ORAL	213931-002	Oct 17, 2023		RX	Yes	No	10,940,146					REDUCTION OF SERUM PHOSPHORUS IN ADULTS
Ardelyx Inc	XPHOZAH	tenapanor hydrochloride	TABLET;ORAL	213931-002	Oct 17, 2023		RX	Yes	No	10,940,146					TREATMENT OF HYPERPHOSPHATEMIA

International Family Members for US Patent 10,940,146

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	095852
Australia	2014250956
Australia	2019204676
Brazil	112015025805